Company Number: SC786400

Analysis Date: 2025-07-29 13:41 UTC

Financial Health Assessment for DERMACONFIDENCE LIMITED

---

1. Financial Health Score: D

Explanation:
The company exhibits significant financial distress indicators, primarily a negative shareholders’ equity and liabilities exceeding assets. As a newly incorporated micro-entity with minimal operating history, it is in an early but vulnerable stage. The financial “vital signs” highlight symptoms of undercapitalisation and liquidity stress, warranting close monitoring and prompt remedial action.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Current Assets	214	Very low cash/debtors; minimal short-term resources
Current Liabilities	1,951	Immediate obligations nearly 10x current assets
Net Current Assets	(1,737)	Negative working capital indicating liquidity strain
Creditors (After 1 Year)	2,000	Medium-term liabilities adding to financial burden
Shareholders Funds (Equity)	(3,737)	Negative net worth signals accumulated losses or funding gap

Interpretation:

• Negative net current assets ("working capital deficit") is a clear symptom of cash flow pressure; the company may struggle to meet short-term obligations on time.
• Negative shareholders’ funds reflect that total liabilities exceed total assets, a classic sign of financial distress or undercapitalisation.
• The company has no recorded employees or fixed assets, suggesting limited operational activity or investment to date.
• Being a micro-entity, it benefits from simplified reporting but this also limits detailed insight into profitability and cash flows.

---

3. Diagnosis: What the Financial Data Reveals

• Early Stage with Capital Deficiency: The company was incorporated recently (October 2023) and appears to have started operations with insufficient capital injection relative to its liabilities. This “financial malaise” is common in start-ups that may have initial expenses (creditors) exceeding their limited cash or assets.
• Liquidity Symptoms: The negative working capital is a warning sign akin to “shortness of breath” in human health — the company may soon face difficulties paying bills or suppliers, risking operational disruption.
• No Audit and Micro-Entity Reporting: The accounts are unaudited and prepared under micro-entity provisions, so there may be unknown risks or unreported issues. However, this is normal for small, new companies and does not necessarily imply poor governance.
• High Owner Control but Financial Risk: The sole director and 100% shareholder, Mrs Kirsty Rhona Forgan, carries full responsibility and control, which is common but concentrates risk and decision making.

---

4. Recommendations: Steps to Improve Financial Wellness

1. Increase Capital Injection: Infuse additional equity or secure longer-term loans to improve net assets and working capital. This will act like a “blood transfusion” to strengthen the company’s financial system.
2. Improve Cash Management: Tighten control over cash flow, delay non-essential expenditures, and accelerate receivables collection to ease liquidity pressure.
3. Monitor and Reduce Short-Term Liabilities: Negotiate extended payment terms with creditors or restructure debts to avoid strain on cash resources.
4. Build Operational Activity Carefully: Scale operations prudently to avoid overextending the company’s financial capacity. Establish a sustainable revenue stream to improve profitability and reserves.
5. Regular Financial Review: Conduct monthly financial health checks, akin to patient monitoring, to detect early “symptoms” of distress and take corrective action promptly.
6. Consider External Advice: Engage with financial advisors or accountants for cash flow forecasting, tax planning, and funding strategies.

---